Literature DB >> 17707708

Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.

Yuki Washimi1, Masato Ito, Yosuke Morishima, Kanako Taguma, Yoshihide Ojima, Toyonobu Uzawa, Masayuki Hori.   

Abstract

We examined the combined effects of human parathyroid hormone 1-34 (hPTH) and elcatonin (ECT: a synthetic derivative of eel calcitonin) to prevent loss of bone mass, architecture and strength in ovariectomized (OVX) rats. Fifty-four female rats (aged 13 weeks) were assigned to one of nine groups: Sham (fake surgery performed), OVX, ECT (15 U/kg administered), PTH5, PTH10 and PTH20 (5, 10 or 20 microg/kg administered), and E+PTH5, E+PTH10 and E+PTH20 (15 U/kg of ECT and 5, 10 or 20 microg/kg of hPTH administered). The drug or vehicle was subcutaneously administered three times a week for 12 weeks. The femurs were removed at the completion of the experiment. The right distal femoral metaphysis was used for measuring bone mineral density (BMD), analyzing trabecular bone structure by micro-computed tomography (microCT), and conducting the bone strength test, and the left femur was used for histomorphometric analysis. Trabecular bone volume (BV/TV) and other bone mass parameters were greater in the ECT and PTH groups than in the OVX group. The number of nodes (N.Nd/TV) and trabecular number (Tb.N) were significantly greater in the ECT group, and trabecular thickness (Tb.Th) and trabecular bone pattern factor (TBPf) were significantly greater in the PTH group. These results indicate that these drugs preserve the bone architecture by different means. Analysis by means of microCT revealed that BV/TV, Tb.N, fractal D and N.Nd/TV were significantly greater in the E+PTH groups than in the PTH groups at each concentration. Trabecular separation (Tb.Sp) was significantly lower in the E+PTH5 and E+PTH10 groups than in the respective PTH5 and PTH10 groups. When the maximum load was applied in a compression test on the distal femur, the E+PTH groups had higher values than the PTH groups, however, the three point bending strength of the diaphysis of femur in the E+PTH10 and E+PTH20 groups tended to be low compared to those in the PTH10 and PTH20 groups. These results indicate that combination therapy using PTH and ECT preserves the trabecular microarchitecture better than single-drug therapy using ECT or PTH in OVX rats, however, it is necessary to optimize the calcitonin (CT) dosage and administration in order to achieve the optimal combined effect of PTH and CT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707708     DOI: 10.1016/j.bone.2007.06.019

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  14 in total

1.  Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?

Authors:  C B Correa; G V Camargos; M Chatterjee; M F Mesquita; A A Del Bel Cury; I Naert; J Duyck; K Vandamme
Journal:  Osteoporos Int       Date:  2016-12-05       Impact factor: 4.507

2.  Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation.

Authors:  Bashar M Altaani; Ammar M Almaaytah; Suha Dadou; Khouloud Alkhamis; Mousa H Daradka; Wael Hananeh
Journal:  Pharm Res       Date:  2020-04-06       Impact factor: 4.200

3.  Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.

Authors:  Yang Yang; Ali Aghazadeh-Habashi; Arash Panahifar; Yuchin Wu; Krishna H Bhandari; Michael R Doschak
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

4.  Regional variations of vertebral trabecular bone microstructure with age and gender.

Authors:  H Chen; S Shoumura; S Emura; Y Bunai
Journal:  Osteoporos Int       Date:  2008-03-11       Impact factor: 4.507

5.  Effect of intermittent treatment with human Parathyroid Hormone 1-34 in SAMP6 senescence-accelerated mice.

Authors:  Y Washimi; H Chen; A Ito; R Takao; T Uzawa; Y Yamamoto; H Yamada; S Shoumura
Journal:  J Endocrinol Invest       Date:  2009-11-12       Impact factor: 4.256

Review 6.  Measurement of the toughness of bone: a tutorial with special reference to small animal studies.

Authors:  R O Ritchie; K J Koester; S Ionova; W Yao; N E Lane; J W Ager
Journal:  Bone       Date:  2008-06-28       Impact factor: 4.398

7.  Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT.

Authors:  J E M Brouwers; B van Rietbergen; R Huiskes; K Ito
Journal:  Osteoporos Int       Date:  2009-03-05       Impact factor: 4.507

8.  The Effects of Cosmos caudatus on Structural Bone Histomorphometry in Ovariectomized Rats.

Authors:  Norazlina Mohamed; Sharon Gwee Sian Khee; Ahmad Nazrun Shuid; Norliza Muhammad; Farihah Suhaimi; Faizah Othman; Abdul Salam Babji; Ima-Nirwana Soelaiman
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-08       Impact factor: 2.629

Review 9.  Advanced CT bone imaging in osteoporosis.

Authors:  H K Genant; K Engelke; S Prevrhal
Journal:  Rheumatology (Oxford)       Date:  2008-07       Impact factor: 7.580

10.  Effects of multi-deficiencies-diet on bone parameters of peripheral bone in ovariectomized mature rat.

Authors:  Thaqif El Khassawna; Wolfgang Böcker; Parameswari Govindarajan; Nathalie Schliefke; Britta Hürter; Marian Kampschulte; Gudrun Schlewitz; Volker Alt; Katrin Susanne Lips; Miriam Faulenbach; Henriette Möllmann; Daniel Zahner; Lutz Dürselen; Anita Ignatius; Natali Bauer; Sabine Wenisch; Alexander Claus Langheinrich; Reinhard Schnettler; Christian Heiss
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.